Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026
ROCKVILLE, Md., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that it will report third quarter 2026 financial and business results after the market closes on Thursday, October 29, 2026.
Covered in this story
What has happened since
- Supernus Pharmaceuticals Inc is up 3.9% since this was published, 2 days ago.
- Cohen & Steers Inc is up 3.4% since this was published, 2 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $SUPN yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Supernus Pharmaceuticals Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.